Joao Siffert
Keine laufenden Positionen mehr
Vermögen: 534 455 $ am 31.03.2024
Profil
Joao Siffert served as President, Chief Executive Officer & Director at Design Therapeutics, Inc. from 2020 to 2023.
Prior to that, he was the Chief Executive & Medical Officer, Director at Abeona Therapeutics, Inc. from 2019 to 2020.
He also held positions as an Independent Director at Alcobra Ltd.
and Arcturus Therapeutics, Inc. Additionally, he served as the Chief Scientific & Medical Officer at Pfizer Inc. and Avanir Pharmaceuticals, Inc. from 2011 to 2016.
He was also the Chief Medical & Scientific Officer at Avera Pharmaceuticals, Inc. from 2005 to 2007 and the Chief Medical Officer & Vice President at Ceregene, Inc. from 2007 to 2011.
He started his career as an Assistant Professor at Albert Einstein College of Medicine, Inc. and later became a Principal at Beth Israel Medical Center.
He earned an MBA from Columbia Business School and a doctorate from Universidade De Sao Paulo Faculdade De Medicina.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 132 619 ( 0,23% ) | 534 455 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Joao Siffert
| Unternehmen | Position | Ende |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Chief Executive Officer | 25.08.2023 |
| ABEONA THERAPEUTICS INC. | Chief Executive Officer | 23.09.2020 |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Chief Tech/Sci/R&D Officer | 01.10.2018 |
| AVEXIS INC | Director/Board Member | 14.05.2018 |
| AVANIR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01.04.2016 |
Ausbildung von Joao Siffert
| Columbia Business School | Masters Business Admin |
| Universidade De Sao Paulo Faculdade De Medicina | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| DESIGN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Health Services |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Health Technology |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Beth Israel Medical Center
 Beth Israel Medical Center Hospital/Nursing ManagementHealth Services Beth Israel Medical Center provided health care services. The firm operates outpatient care center. The company was headquartered in New York, NY. | Health Services |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
